Position in REGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$3,269,812
+$1,694,812 QoQ
Shares Held
4,232
+41.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $89,889,169 across 7 Biotechnology names. REGN ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
86,697 | $28,685,436 | |
| 2 | INCY |
Incyte Corp
|
259,048 | $24,381,597 | |
| 3 | INSM |
INSMED Inc
|
77,970 | $12,749,654 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,903 | $10,673,645 | |
| 5 | RPRX |
Royalty Pharma plc
|
177,500 | $8,514,675 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
4,232 | $3,269,812 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
16,600 | $1,614,350 |
All Filings in REGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,269,812 | 4,232 | Shares | Sole | 2026-05-08 | |
| 2025-06-30 | $1,575,000 | 3,000 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $13,635,945 | 21,500 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $23,649,356 | 33,200 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $27,647,612 | 26,300 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $45,614,702 | 43,400 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $25,505,985 | 26,500 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,944,744 | 13,600 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $5,596,128 | 6,800 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $7,400,962 | 10,300 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $8,134,533 | 9,900 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,719,943 | 10,700 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,717,621 | 8,300 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,265,978 | 10,600 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $6,252,048 | 9,900 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $4,841,440 | 8,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,742,218 | 6,700 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $2,705,416 | 5,600 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $8,060,832 | 14,400 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,916,035 | 15,900 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $8,105,614 | 16,600 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||